[1]
|
Wakefield, T.W., McLafferty, R.B., Lohr, J.M., Caprini, J.A., Gillespie, D.L. and Passman, M.A., on Behalf of the Executive Committee of the American Venous Forum (2009) Call to Action to Prevent Venous Thromboembolism. Journal of Vascular Surgery, 49, 1620-1623.
https://doi.org/10.1016/j.jvs.2009.01.058
|
[2]
|
Heit, J.A. (2005) Venous Thromboembolism: Disease Burden, Outcomes and Risk Factors. Journal of Thrombosis and Haemostasis, 3, 1611-1617.
https://doi.org/10.1111/j.1538-7836.2005.01415.x
|
[3]
|
Heinemann, L.A.J. and Dinger, J.C. (2007) Range of Published Estimates of Venous Thromboembolism Incidence in Young Women. Contraception, 75, 328-336.
https://doi.org/10.1016/j.contraception.2006.12.018
|
[4]
|
Seaman, H.E., de Vries, C.S. and Farmer, R.D.T. (2004) Venous Thromboembolism Associated with Cyproterone Acetate in Combination with Ethinyloestradiol (Dianette): Observational Studies Using the UK General Practice Research Database. Pharmacoepidemiology and Drug Safety, 13, 427-436. https://doi.org/10.1002/pds.896
|
[5]
|
Eisenberger, A. and Westhoff, C. (2014) Hormone Replacement Therapy and Venous Thromboembolism. Journal of Steroid Biochemistry and Molecular Biology, 142, 76-82.
https://doi.org/10.1016/j.jsbmb.2013.08.016
|
[6]
|
Rabe, T., Luxembourg, B., Ludwig, M., Dinger, J.C., Bauersachs, R., Rott, H., Mueck, A.O. and Albring, C. (2011) Contraception and Thrombophilia—A Statement from the German Society of Gynecological Endocrinology and Reproductive Medicine and the Professional Association of the German Gynaecologists. Journal of Reproductive Medicine and Endocrinology, 8, 178-218.
|
[7]
|
James, A.H., Jamison, M.G., Brancazio, L.R. and Myers, E.R. (2006) Venous Thromboembolism during Pregnancy and the Postpartum Period: Incidence, Risk Factors, and Mortality. AJOG, 194, 1311-1315. https://doi.org/10.1016/j.ajog.2005.11.008
|
[8]
|
Wu, P., Poole, T.C., Pickett, J.A., Bhat, A. and Lees, C.C. (2013) Current Obstetric Guidelines on Thromboprophyaxis in the United Kingdom: Evidence Based Medicine? European Journal of Obstetrics & Gynecology and Reproductive Biology, 168, 7-11.
https://doi.org/10.1016/j.ejogrb.2012.12.022
|
[9]
|
Abbasi, N., Balayla, J., Laporta, D.P., Kezouh, A. and Abenhaim, H.A. (2014) Trends, Risk Factors and Mortality among Women with Venous Thromboembolism during Labour and Delivery: A Population-Based Study of 8 Million Births. Archives of Gynecology and Obstetrics, 289, 275-284. https://doi.org/10.1007/s00404-013-2923-8
|
[10]
|
Say, L., Gemmill, A., Tuncalp, Ö., et al. (2014) Global Causes of Maternal Death: A WHO Systematic Analysis. Lancet Global Health, 2, e323-e333.
https://doi.org/10.1016/s2214-109x(14)70227-x
|
[11]
|
Clark, S.L. (2012) Strategies for Reducing Maternal Mortality. Seminars in Perinatology, 36, 42-47. https://doi.org/10.1053/j.semperi.2011.09.009
|
[12]
|
Heit, J., Kobbervig, C. and James, A. (2005) Trends in the Incidence of Venous Thromboembolism during Pregnancy or Postpartum: A 30-Year Population-Based Study. Annals of Internal Medicine, 143, 697-706.
https://doi.org/10.7326/0003-4819-143-10-200511150-00006
|
[13]
|
Salonen Ros, H., Lichtenstein, P., Bellocco, R., Petersson, G. and Cnattingius, S. (2001) Increased Risks of Circulatory Diseases in Late Pregnancy and Puerperium. Epidemiology, 12, 456-460. https://doi.org/10.1097/00001648-200107000-00016
|
[14]
|
Pomp, E., Lenselink, A., Rosendaal, F. and Doggen, C. (2008) Pregnancy, the Postpartum Period and Prothrombotic Defects: Risk of Venous Thrombosis in the MEGA Study. Journal of Thrombosis and Haemostasis, 6, 632-637.
https://doi.org/10.1111/j.1538-7836.2008.02921.x
|
[15]
|
Reid, R.L., Westhoff, C., Mansour, D., de Vries, C., Verhaeghe, J., Boschitsch, E., Gompel, A., Birkhauser, M., Krepelka, P., Dulicek, P., Iversen, O.-E., Khamoshina, M., Vrabic Dezman, L., Fruzzetti, F., Szarewski, A., Wilken-Jensen, C., Seidman, D., Kaaja, R. and Shapiro, S. (2010) Oral Contraceptives and Venous Thromboembolism Consensus Opinion from an International Workshop held in Berlin, Germany in December 2009. Journal of Family Planning and Reproductive Health Care, 36, 117-122.
https://doi.org/10.1783/147118910791749425
|
[16]
|
Tsai, A., Cushman, M., Rosamond, W., Heckbert, S., Polak, J. and Folsom, A. (2002) Cardiovascular Risk Factors and Venous Thromboembolism Incidence: The Longitudinal Investigation of Thromboembolism Etiology. Archives of Internal Medicine, 162, 1182-1189.
https://doi.org/10.1001/archinte.162.10.1182
|
[17]
|
Hoist, A., Jensen, G. and Prescott, E. (2010) Risk Factors for Venous Thromboemobolism: Results from the Copenhagen City Heart Study. Circulation, 121, 1896-1903.
https://doi.org/10.1161/CIRCULATIONAHA.109.921460
|
[18]
|
Suchon, P., Al Frouh, F., Henneuse, A., et al. (2015) Risk Factors for Venous Thromboembolism in Women under Combined Oral Contraceptive. The PILI Genetic Risk Monitoring (PILGRIM) Study. Thrombosis and Haemostasis, 115, 135-142.
https://doi.org/10.1160/TH15-01-0045
|
[19]
|
ACOG Clinical (2010) Practice Guideline No. 110: Non-Contraceptive Uses of Hormonal Contraceptives. Obstetrics & Gynecology, 115, 206-218.
https://doi.org/10.1097/AOG.0b013e3181cb50b5
|
[20]
|
Okoroh, E., Hooper, W., Atrash, H., Yusuf, H. and Boulet, S. (2012) Is Polycystic Ovary Syndrome another Risk Factor for Venous Thromboembolism? United States, 2003-2008. American Journal of Obstetrics and Gynecology, 207, 377.e1-377.e8.
https://doi.org/10.1016/j.ajog.2012.08.007
|
[21]
|
Bird, S.T., Hartzema, A.G., Brophy, J.M., Etminan, M. and Delaney, J.A. (2013) Risk of Venous Thromboembolism in Women with Polycystic Ovarian Syndrome: A Population-Based Matched Cohort Analysis. CMAJ, 185, E115-E120.
https://doi.org/10.1503/cmaj.120677
|
[22]
|
Seaman, H.E., de Vries, C.S. and Farmer, R.D.T. (2003) The Risk of Venous Thromboembolism in Women Prescribed Cyproterone Acetate in Combination with Ethinyl Estradiol: A Nested Cohort Analysis and Case Control Study. Human Reproduction, 18, 522-526.
https://doi.org/10.1093/humrep/deg120
|
[23]
|
McLaughlin, D., Wade, C., Champion, H., Salinas, J. and Holcomb, J. (2009) Thromboembolic Complications Following Trauma. Transfusion, 49, 256S-263S.
https://doi.org/10.1111/j.1537-2995.2008.01989.x
|
[24]
|
White, R., Zhou, H. and Romano, P. (2003) Incidence of Symptomatic Venous Thromboembolism after Different Elective or Urgent Surgical Procedures. Thrombosis and Haemostasis, 90, 446-455.
|
[25]
|
Yamada, N., Hanzawa, K., Ota, S., et al. (2015) Occurrence of Deep Vein Thrombosis among Hospitalized Non-Surgical Japanese Patients. Annals of Vascular Diseases, 8, 203-209. https://doi.org/10.3400/avd.oa.14-00132
|
[26]
|
Jaffer, A., Barsoum, W., Krebs, V., Hurbanek, J., Morra, N. and Brotman, D. (2005) Duration of Anesthesia and Venous Thromboembolism after Hip and Knee Arthroplasty. Mayo Clinic Proceedings, 80, 732-738. https://doi.org/10.1016/S0025-6196(11)61526-7
|
[27]
|
Geerts, W., Jay, R. and Code, K. (1996) A Comparison of Low-Dose Heparin with low-Molecular-Weight Heparin as Prophylaxis against Venous Thromboembolism after Major Trauma. New England Journal of Medicine, 335, 701-707.
https://doi.org/10.1056/NEJM199609053351003
|
[28]
|
Geerts, W., Pineo, G., Heit, J., et al. (2004) Prevention of Venous Thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 126, 338S-400S. https://doi.org/10.1378/chest.126.3_suppl.338S
|
[29]
|
Elting, L., Escalante, C. and Cooksley, C. (2004) Outcomes and Cost of Deep Venous Thrombosis among Patients with Cancer. Archives of Internal Medicine, 164, 1653-1661.
https://doi.org/10.1001/archinte.164.15.1653
|
[30]
|
Blom, J.W., Doggen, C.J., Osanto, S. and Rosendaal, F.R. (2005) Malignancies, Prothrombotic Mutations, and the Risk of Venous Thrombosis. JAMA, 293, 715-722.
https://doi.org/10.1001/jama.293.6.715
|
[31]
|
Prandoni, P., Lensing, A.W., Büller, H.R., et al. (1992) Deep-Vein Thrombosis and the Incidence of Subsequent Symptomatic Cancer. New England Journal of Medicine, 327, 1128-1133. https://doi.org/10.1056/NEJM199210153271604
|
[32]
|
Ageno, W., Becattini, C., Brighton, T., Selby, R. and Kamphuisen, P. (2008) Cardiovascular Risk Factors and Venous Thromboembolism: A Meta-Analysis. Circulation, 117, 93-102.
https://doi.org/10.1161/CIRCULATIONAHA.107.709204
|
[33]
|
Pomp, E., Rosendaal, F. and Doggen, C. (2008) Smoking Increases the Risk of Venous Thrombosis and Acts Synergistically with Oral Contraceptive Use. American Journal of Hematology, 83, 97-102. https://doi.org/10.1002/ajh.21059
|
[34]
|
Gavish, I. and Brenner, B. (2011) Air Travel and Risk of Thromboembolism. Internal and Emergency Medicine, 6, 113-116. https://doi.org/10.1007/s11739-010-0474-6
|
[35]
|
Cannegieter, S.C., Doggen, C.J.M., van Houwelingen, H.C. and Rosendaal, F.R. (2006) Travel-Related Venous Thrombosis: Results from a Large Population-Based Case Control Study (MEGA Study). PLoS Medicine, 3, e307.
https://doi.org/10.1371/journal.pmed.0030307
|
[36]
|
Martinelli, I., Taioli, E., Battaglioli, T., Podda, G.M., Passamonti, S.M., Pedotti, P. and Mannucci, P.M. (2003) Risk of Venous Thromboembolism after Air Travel: Interaction with Thrombophilia and Oral Contraceptives Archives of Internal Medicine, 163, 2771-2774. https://doi.org/10.1001/archinte.163.22.2771
|
[37]
|
Silverstein, M.D., Heit, J.A., Mohr, D.N., Petterson, T.M., O’Fallon, W.M. and Melton, L.J. (1998) Trends in the Incidence of Deep Vein Thrombosis and Pulmonary Embolism:A Twenty-Five Year Population Based Study. Archives of Internal Medicine, 158, 585-593.
https://doi.org/10.1001/archinte.158.6.585
|
[38]
|
Oger, E. (2000) Incidence of Venous Thromboembolism: A Community-Based Study in Western France. EPI-GETBP Study Group. Groupe d’Etude de la Thrombose de Bretagne Occidentale. Thrombosis and Haemostasis, 83, 657-660.
|
[39]
|
Lidegaard, Ø., Nielsen, L.H., Skovlund, C.W., Skjeldestad, F.E. and Løkkegaard, E. (2011) Risk of Venous Thromboembolism from Use of Oral Contraceptives Containing Different Progestogens and Oestrogen Doses: Danish Cohort Study, 2001-9. BMJ, 343, d6423.
https://doi.org/10.1136/bmj.d6423
|
[40]
|
Roach, R.E.J., Lijfering, W.M., Helmerhorst, F.M., Cannegieter, S.C., Rosendaal, F.R. and Van Hylckama Vlieg, A. (2012) The Risk of Venous Thrombosis in Women over 50 Years Old Using Oral Contraception or Postmenopausal Hormone Therapy. Journal of Thrombosis and Haemostasis, 11, 124-131. https://doi.org/10.1111/jth.12060
|
[41]
|
Sode, B.F., Allin, K.H., Dahl, M., Gyntelberg, F. and Nordestgaard, B.G. (2013) Risk of Venous Thromboembolism and Myocardial Infarction Associated with Factor V Leiden and Prothrombin Mutations and Blood Type. CMAJ, 185, E229-E237.
|
[42]
|
Guimaraes, D.A., dos Santos, M.S., Gomes, K.B., van der Bom, J.G., Rios, D.R., Cardoso, J., Franco, R.M., Teixeira, G.S., Dusse, L.M., Carvalho, M. and Fernandes, A.P. (2012) Interaction between Oral Estrogen plus Progestogen Therapy and ABO Blood Groups on Coagulation Activation in Postmenopausal Women. Menopause, 19, 339-345.
https://doi.org/10.1097/gme.0b013e31822b721f
|
[43]
|
Bezemer, I.D., van der Meer, F.J., Eikenboom, J., Rosendaal, F.R. and Doggen, C.J. (2009) The Value of Family History as a Risk Indicator for Venous Thrombosis. Archives of Internal Medicine, 169, 610-615. https://doi.org/10.1001/archinternmed.2008.589
|
[44]
|
Vandenbroucke, J.P., van der Meer, F.J., Eikenboom, J. and Rosendaal, F.R. (1996) Factor V Leiden: Should We Screen Oral Contraceptive Users and Pregnant Women? BMJ, 313, 1127-1130. https://doi.org/10.1136/bmj.313.7065.1127
|
[45]
|
Wu, O., Robertson, L., Twaddle, S., Lowe, G.D., Clark, P., Greaves, M., Walker, I.D., Langhorne, P., Brenkel, I., Regan, L. and Greer, I. (2006) Screening for Thrombophilia in High-Risk Situations: Systematic Review and Cost-Effectiveness Analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Health Technology Assessment, 10, 1-110. https://doi.org/10.3310/hta10110
|
[46]
|
Vandenbroucke, J.P., Koster, T., Briet, E., Reitsma, P.H., Bertina, R.M. and Rosendaal, F.R. (1994) Increased Risk of Venous Thrombosis in Oral-Contraceptive Users Who Are Carriers of Factor V Leiden Mutation. Lancet, 344, 1453-1457.
https://doi.org/10.1016/S0140-6736(94)90286-0
|
[47]
|
Bezemer, I.D., Bare, L.A., Doggen, C.J., Arellano, A.R., Tong, C., Rowland, C.M., Catanese, J., Young, B.A., Reitsma, P.H., Devlin, J.J. and Rosendaal, F.R. (2008) Gene Variants Associated with Deep Vein Thrombosis. JAMA, 299, 1306-1314.
https://doi.org/10.1001/jama.299.11.1306
|
[48]
|
Rosendaal, F.R., Doggen, C.J., Zivelin, A., Arruda, V.R., Aiach, M., Siscovick, D.S., Hillarp, A., Watzke, H.H., Bernardi, F., Cumming, A.M., Preston, F.E. and Reitsma, P.H. (1998) Geographic Distribution of the 20210 G to A Prothrombin Variant. Thrombosis and Haemostasis, 79, 706-708.
|
[49]
|
Poort, S.R., Rosendaal, F.R., Reitsma, P.H. and Bertina, R.M. (1996) A Common Genetic Variation in the 3’-Untranslated Region of the Prothrombin Gene Is Associated with Elevated Plasma Prothrombin Levels and an Increase in Venous Thrombosis. Blood, 88, 3698-3703.
|
[50]
|
Rees, D.C., Cox, M. and Clegg, J.B. (1995) World Distribution of Factor V Leiden. Lancet, 346, 1133-1134. https://doi.org/10.1016/S0140-6736(95)91803-5
|
[51]
|
Lee, D.H., Henderson, P.A. and Blajchman, M.A. (1996) Prevalence of Factor V Leiden in a Canadian Blood Donor Population. CMAJ, 155, 285-289.
|
[52]
|
Price, D.T. and Ridker, P.M. (1997) Factor V Leiden Mutation and the Risks for Thromboembolic Disease: A Clinical Perspective. Annals of Internal Medicine, 127, 895-903.
https://doi.org/10.7326/0003-4819-127-10-199711150-00007
|
[53]
|
Rosendaal, F.R., Koster, T., Vandenbroucke, J.P. and Reitsma, P.H. (1995) High Risk of Thrombosis in Patients Homozygous for Factor V Leiden (Activated Protein C Resistance). Blood, 85, 1504-1508.
|
[54]
|
Miletich, J., Sherman, L. and Broze Jr., G. (1987) Absence of Thrombosis in Subjects with Heterozygous Protein C Deficiency. New England Journal of Medicine, 317, 991-996.
https://doi.org/10.1056/NEJM198710153171604
|
[55]
|
Tait, R.C., Walker, I.D., Reitsma, P.H., Islam, S.I., McCall, F., Poort, S.R., Conkie, J.A. and Bertina, R.M. (1995) Prevalence of Protein C Deficiency in the Healthy Population. Thrombosis and Haemostasis, 73, 87-93.
|
[56]
|
Martinelli, I., Mannucci, P.M., De Stefano, V., Taioli, E., Rossi, V., Crosti, F., Paciaroni, K., Leone, G. and Faioni, E.M. (1998) Different Risks of Thrombosis in Four Coagulation Defects Associated with Inherited Thrombophilia: A Study of 150 Families. Blood, 92, 2353-2358.
|
[57]
|
Koster, T., Rosendaal, F.R., Briet, E., van der Meer, F.J., Colly, L.P., Trienekens, P.H., Poort, S.R., Reitsma, P.H. and Vandenbroucke, J.P. (1995) Protein C Deficiency in a Controlled Series of Unselected Outpatients: An Infrequent but Clear Risk Factor for Venous Thrombosis (Leiden Thrombophilia Study). Blood, 85, 2756-2761.
|
[58]
|
Di Minno, M.N., Ambrosino, P., Ageno, W., Rosendaal, F., Di Minno, G. and Dentali, F. (2015) Natural Anticoagulants Deficiency and the Risk of Venous Thromboembolism: A Meta-Analysis of Observational Studies. Thrombosis Research, 135, 923-932.
https://doi.org/10.1016/j.thromres.2015.03.010
|
[59]
|
Dykes, A.C., Walker, I.D., McMahon, A.D., Islam, S.I. and Tait, R.C.A. (2001) Study of Protein S Antigen Levels in 3788 Healthy Volunteers: Influence of Age, Sex and Hormone Use, and Estimate for Prevalence of Deficiency State. British Journal of Haematology, 113, 636-641. https://doi.org/10.1046/j.1365-2141.2001.02813.x
|
[60]
|
Tait, R.C., Walker, I.D., Perry, D.J., Islam, S.I., Daly, M.E., McCall, F., Conkie, J.A. and Carrell, R.W. (1994) Prevalence of Antithrombin Deficiency in the Healthy Population. British Journal of Haematology, 87, 106-112.
https://doi.org/10.1111/j.1365-2141.1994.tb04878.x
|
[61]
|
Trussell, J. (2011) Contraceptive Failure in the United States. Contraception, 83, 397-404.
https://doi.org/10.1016/j.contraception.2011.01.021
|
[62]
|
Van Vlijmen, E.F.W., Veeger, N.J.G.M., Middledorp, S., Hamulyak, K., Prins, M.H., Buller, H.R. and Meijer, K. (2011) Thrombotic Risk during Oral Contraceptive Use and Pregnancy in Women with Factor V Leiden or Prothrombin Mutation: A Rational Approach to Contraception. Blood, 188, 2055-2061. https://doi.org/10.1182/blood-2011-03-345678
|
[63]
|
Van Hylckama Vlieg, A., Helmerhorst, F. and Rosendaal, F. (2010) The Risk of Deep Venous Thrombosis Associated with Injectable Depot-Medroxyprogesterone Acetate Contraceptives or a Levonorgestrel Intrauterine Device. Arteriosclerosis Thrombosis and Vascular Biology, 30, 2297-2300. https://doi.org/10.1161/ATVBAHA.110.211482
|
[64]
|
Mantha, S., Karp, R., Raghavan, V., Terrin, N., Bauer, K.A. and Zwicker, J.I. (2012) Assessing the Risk of Venous Thromboembolic Events in Women Taking Progestin-Only Contraception: A Meta-Analysis. BMJ, 345, e4944. https://doi.org/10.1136/bmj.e4944
|
[65]
|
Lidegaard, O., Nielsen, L.H., Skovlund, C.W. and lokkegaard, E. (2012) Venous Thrombosis in Users of Non-Oral Hormonal Contraception: Follow up Study, Denmark 2001-10. BMJ, 344, e2990. https://doi.org/10.1136/bmj.e2990
|
[66]
|
Godfrey, E.M., Folger, S.G., Jeng, G., Jamieson, D.J. and Curtis, K.M. (2013) Treatment of Bleeding Irregularities in Women with Copper-Containing IUDs: A Systematic Review. Contraception, 87, 549-566. https://doi.org/10.1016/j.contraception.2012.09.006
|
[67]
|
Dore, D.D., Norman, H., Loughlin, J. and Seeger, J.D. (2010) Extended Case-Control Study Results on Thromboembolic Outcomes among Transdermal Contraceptive Users. Contraception, 81, 408-413. https://doi.org/10.1016/j.contraception.2009.12.009
|
[68]
|
Dinger, J., Mohner, S. and Heinemann, K. (2013) Cardiovascular Risk Associated with the Use of the Etonorgestrel-Containing Vaginal Ring. Obstetrics & Gynecology, 122, 800-808.
https://doi.org/10.1097/AOG.0b013e3182a5ec6b
|
[69]
|
Gerstman, B.B., Piper, J.M., Tomita, D.K., Ferguson, W.J., Stadel, B.V. and Lundin, F.E. (1991) Oral Contraceptive Estrogen Dose and the Risk of Deep Venous Thromboembolic Disease. American Journal of Epidemiology, 133, 32-37.
|
[70]
|
Dinger, J.C., Heinemann, L.A.J. and Kuhl-Habich, D. (2007) The Safety of a Drospirenone-Containing Oral Contraceptive: Final Results from the European Active Surveillance Study on Oral Contraceptives Based on 142,475 Women-Years of Observation. Contraception, 75, 344-354. https://doi.org/10.1016/j.contraception.2006.12.019
|
[71]
|
Grimes, D.A. (2010) Epidemiologic Research Using Administrative Databases: Garbage in, Garbage out. Obstetrics & Gynecology, 116, 1018-1019.
https://doi.org/10.1097/AOG.0b013e3181f98300
|
[72]
|
Dinger, J. and Shapiro, S. (2012) Interpreting Large but Incomplete Datasets. Journal of Family Planning and Reproductive Health Care, 38, 2-6.
https://doi.org/10.1136/jfprhc-2011-100260
|
[73]
|
Heinemann, L.A.J., Dinger, J.C., Assmann, A. and Minh, T.D. (2010) Use of Oral Contraceptives Containing Gestodene and Risk of Venous Thromboembolism: Outlook 10 Years after the Third-Generation “Pill Scare”. Contraception, 18, 401-407.
https://doi.org/10.1016/j.contraception.2009.12.014
|
[74]
|
Dinger, J., Assmann, A., Mohner, S. and Minh, T.D. (2010) Risk of Venous Thromboembolism and the Use of Dienogest- and Drospirenone-Containing Oral Contraceptives: Results from a German Case-Control Study. Journal of Family Planning and Reproductive Health Care, 36, 123-129. https://doi.org/10.1783/147118910791749416
|
[75]
|
Dinger, J., Bardenheuer, K. and Hienemann, K. (2014) Cardiovascular and General Safety of a 24-Day Regimen of Drospirenone-Containing Combined Oral Contraceptives: Final Results from the International Active Surveillance Study of Women Taking Oral Contraceptives. Contraception, 89, 253-263. https://doi.org/10.1016/j.contraception.2014.01.023
|
[76]
|
Reid, R.L. (2014) Oral Hormonal Contraception and Venous Thromboembolism (VTE). Contraception, 89, 235-236. https://doi.org/10.1016/j.contraception.2014.02.002
|
[77]
|
Bloemenkamp, K.W., Rosendaal, F.R., Helmerhorst, F.M. and Vandenbroucke, J.P. (2000) Higher Risk of Venous Thrombosis during Early Use of Oral Contraceptives in Women with Inherited Clotting Defects. Archives of Internal Medicine, 160, 49-52.
https://doi.org/10.1001/archinte.160.1.49
|
[78]
|
Suissa, S., Spitzer, W.O., Rainville, B., Cusson, J., Lewis, M. and Heinemann, L. (2000) Recurrent Use of Newer Oral Contraceptives and the Risk of Venous Thromboembolism. Human Reproduction, 15, 817-821. https://doi.org/10.1093/humrep/15.4.817
|
[79]
|
Bergendal, A., Odlind, V., Persson, I. and Kieler, H. (2009) Limited Knowledge on Progestogen-Only Contraception and Risk of Venous Thromboembolism. Acta Obstetricia et Gynecologica, 88, 261-266. https://doi.org/10.1080/00016340902730375
|
[80]
|
World Health Organization Collaborative Study of cardiovascular Disease and Steroid Hormone Contraception (1998) Cardiovascular Disease and Use of Oral and Injectable Progestogen-Only Contraceptives and Combined Injectable Contraceptives: Results of an International, Multicenter, Case-Control Study. Contraception, 57, 315-324.
|
[81]
|
Heinemann, L.A.J., Assmann, A., DoMinh, T. and Garbe, E. (1999) Oral Progestogen-Only Contraceptives and Cardiovascular Risk: Results from the Transnational Study on Oral Contraceptives and the Health of Young Women. European Journal of Contraception and Reproductive Health Care, 4, 67-73. https://doi.org/10.3109/13625189909064007
|